Dasatinib

- Overview
  - Dasatinib is multitarget kinase inhibitor used in the treatment of leukemia. Dasatinib's main targets are tyrosine kinase BCR/ABL, which works to provide the cancer cell with ATP at an uncontrolled rate causing rapid division, and the SRC family of kinases, which contribute to the malignant migration of cancers.
    
    Dasatinib is slightly soluble in ethanol and methanol, but insoluble in water.
    
    This product is considered a dangerous good. Quantities above 1 g may be subject to additional shipping fees. Please contact us for specific questions.
    
    Please contact us at for specific academic pricing.
    
    Background
    
    Dasatinib is able to bind to the kinase domain of both the active and inactive forms of BCR/ABL for more effective inhibiting power.
- Properties
  - CAS Number
    
    302962-49-8
    
    Molecular Formula
    
    C22H26ClN7O2S
    
    Molecular Weight
    
    488.01
    
    Appearance
    
    White to off-white powder
    
    Storage
    
    -20°C
    
    * For research use only